AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06798311 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SUPPORT workbook
Description: The SUPPORT workbook contains a template for how pelvic floor physical therapy is delivered in the typical in-person setting with a combination of education, bladder re-training exercises, pelvic floor stretching and core strengthening. To aid in the demonstration of physical therapy exercises, the workbook includes QR-coded links to videos of a physical therapist performing the exercises in an ideal form. The videos include audio instruction to ensure that patients can learn the concepts in either visual, auditory or written form. The cognitive behavioral therapy (CBT) portion of the workbook is adapted from the standardized CBT protocol and includes short introductions and exercises pertaining to cognitive flexibility, behavioral activation and social support. The total time commitment for the program is 2-hours per week.~Patients also will be given access to a custom programmed GPT trained on the SUPPORT workbook and given instructions on empathetic communication techniques.
Study NCT06798961 — intervention group
Intervention type: PROCEDURE
Intervention: Ablation
Description: Patient treated with an ablation to eliminate the accessory conduction pathway in the heart.
Study NCT06798961 — intervention group
Intervention type: PROCEDURE
Intervention: Standard of care without ablation
Description: Patient diagnosed with accessory pathway but elected against cardiac ablation as a treatment option at the time of diagnosis.
Study NCT06798428 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract )
Description: Group (A)will have GL, CH and natural herbs phonophoresis .Ultrasound parameters are 1 W/cm for intensity, 1 MHz for frequency and 5 min continuous mode then 5 min pulsed mode. The device that will be used is medserve, England (the head of the device is 5cm).
Study NCT06798428 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group B will receive ultrasound with topical gel , same parameter as group A
Description: Ultrasound parameters are 1 W/cm for intensity, 1 MHz for frequency and 5 min continuous mode then 5 min pulsed mode. The device that will be used is medserve, England (the head of the device is 5cm). Topical gel with no drugs
Study NCT06798428 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Group C sham ultrasound for massage - 5 minutes
Description: sham ultrasound for massage - 5 minutes
Study NCT05501548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib 300mg by mouth twice daily
Study NCT05501548 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Ascorbic acid 1g/kg administered intravenously twice weekly
Study NCT06800261 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sinovac PCV24
Description: Sinovac PCV24 (0.5 mL) is administered intramuscularly according to different immunization schedules.
Study NCT06800261 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar®
Description: Prevnar® (0.5 mL) is administered intramuscularly according to different immunization schedules.
Study NCT06797063 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BEST4Baby
Description: BEST4Baby consists of prenatal and post-delivery breastfeeding education and support for mothers provided by community-based peer counselors who are trained in a modified 5-day WHO/UNICEF Breastfeeding Counselling Course and supported by an mHealth application.
Study NCT06797063 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Usual Care
Description: Participants in the control clusters will continue with local practice for antenatal breastfeeding support and referral to facilities. It is expected that they will receive routine health education recommended by the national health system during the prenatal and postnatal period and offered through PHC and community level workers, including ASHAs. ASHAs may visit a woman after delivery to provide lactation support, as needed, with visits ceasing at 42 days post-delivery. Breastfeeding mothers requiring advanced lactation support may be referred to a community subcenter for care with more skilled clinicians.
Study NCT06793839 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Enhanced Ultrasonography localizing microscopy
Description: 3 bilateral transcranial enhanced (with Sonovue) ultrasonography per patient to visualize cranial arteries of the anterior circulation of the brain
Study NCT06796439 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching
Description: Participants will be divided into two groups with sample size of 52 participants in each group.~Group 1: Participants will perform static Stretching protocols. There were no special warm-up exercises (running and skipping) after the implementation of static stretching exercises. After the general warm-up, participants would engage in a sequence of randomized static stretches including Lower back stretch, Quads stretch, Hams Stretch, Calf Stretch and Upper limb Stretches (biceps, Triceps, Arm across chest, Arm pull and head tilt, Side stretch, backward arm stretch, Pect. stretch and Towel Stretch). All stretches were done as 3 sets of 30 seconds for 20 minutes for 5 days per week and held at the point of mild discomfort. Readings will be taken after 1st, 3rd and 6th week, respectively.~Group 2: Participants will perform Dynamic Stretching protocols. There were no special warm-up exercises (running and skipping) after the implementation of dynamic stretching exercises. Participants wou
Study NCT06796439 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Stretching
Description: Group 2: Participants will perform Dynamic Stretching protocols. There were no special warm-up exercises (running and skipping) after the implementation of dynamic stretching exercises. Participants would engage in a sequence of randomized static stretches including Jumping Jacks, Lunges, Trunk Circles, arm swings and butt Kicks. All stretches were done as 3 sets of 30 seconds for 20mins for 5 days per week and held at the point of mild discomfort. Readings will be taken after 1st, 3rd and 6th week, respectively.
Study NCT06379984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: Sublingual buprenorphine
Study NCT06379984 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Buprenorphine
Description: Sublingual buprenorphine
Study NCT06792903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CG101 high dose + artificial tear
Description: Patient in this group received high dose CG101 eyedrops twice daily and artificial tear three times a day during week 0 to week 4, after 4 week washout, patient in this group cross over to receive placebo CG101 eyedrops twice daily and artificial tear three times a day during week 8 to week 12.
Study NCT06792903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CG101 low dose + artificial tear
Description: Patient in this group received low dose CG101 eyedrops twice daily and artificial tear three times a day during week 0 to week 4, after 4 week washout, patient in this group cross over to receive high dose CG101 eyedrops twice daily and artificial tear three times a day during week 8 to week 12.
Study NCT06792903 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CG101 low dose + artificial tear
Description: Patient in this group received low dose CG101 eyedrops twice daily and artificial tear three times a day during week 0 to week 4, after 4 week washout, patient in this group cross over to receive high dose CG101 eyedrops twice daily and artificial tear three times a day during week 8 to week 12.
Study NCT06792903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo + artificial tear
Description: Patient in this group received placebo dose CG101 eyedrops twice daily and artificial tear three times a day during week 0 to week 4, after 4 week washout, patient in this group cross over to receive low dose CG101 eyedrops twice daily and artificial tear three times a day during week 8 to week 12.
Study NCT06792903 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo + artificial tear
Description: Patient in this group received placebo dose CG101 eyedrops twice daily and artificial tear three times a day during week 0 to week 4, after 4 week washout, patient in this group cross over to receive low dose CG101 eyedrops twice daily and artificial tear three times a day during week 8 to week 12.
Study NCT06793306 — intervention group
Intervention type: OTHER
Intervention: Age
Description: Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35
Study NCT06793306 — intervention group
Intervention type: OTHER
Intervention: combination therapy
Description: To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer
Study NCT06796400 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General exercises
Description: 4 general exercises were done by control group with 10 repetitions and 3 sets, 6 times per week, up to 8 weeks.These exercises are for lower trapzius and serratus anterior mucles strengthing.
Study NCT06796400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theraband exerises
Description: 5 Thera-band exercises were completed by experimental group with 3 sets and 10 repetitions, 6 times per week, up to 8 weeks. These exercises are for lower trapzius and serratus anterior mucles strengthing.
Study NCT06307652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg
Description: 1 capsule of balcinrenone/dapagliflozin 15 mg/10 mg and 1 tablet of matching placebo for dapagliflozin 10 mg once daily, oral use
Study NCT06307652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg
Description: 1 capsule of balcinrenone/dapagliflozin 40 mg/10 mg and 1 tablet of matching placebo for dapagliflozin 10 mg once daily, oral use
Study NCT06307652 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dapagliflozin 10 mg and matching placebo for balcinrenone/dapagliflozin
Description: 1 tablet of dapagliflozin 10 mg and 1 capsule of matching placebo for balcinrenone/dapagliflozin once daily, oral use
Study NCT06795607 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: The experimental product is a dietary supplement manufactured by Cerbios-Pharma S.A, Each stick contains probiotic live cultures of Enterococcus lactis SF68® at a concentration of 10\^9 CFU, phytosterols, 6S-5MeTHF, maltose and silicon dioxide. Study participants will be given N°3 packs each containing 30 stick packs of 1.7 g each, in granulated form in sufficient quantity for the entire duration of the study (12 weeks). Subjects will be required to consume N°1 stick pack of the supplement daily after dinner for 12 continuous weeks. The product should be placed directly on the tongue and should be taken without water. After taking the product, the subject should drink half a glass of water to promote solubilization and transit. The supplement should be stored in a cool, dry place, away from light, moisture and direct heat sources to ensure the viability of the probiotic strain until the expiration date.
Study NCT06795607 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: N°1 stick/day of placebo food supplement (i.e., stick without added probiotics), with the same intake modalities as probiotic.
Study NCT06794697 — intervention group
Intervention type: OTHER
Intervention: Questionnaire including APAIS scale
Description: Patients will complete a questionnaire in two stages : upon admission and just before leaving for the operating room
Study NCT06793826 — intervention group
Intervention type: BIOLOGICAL
Intervention: DTaP-IPV-Hep B-PRP-T combined vaccine
Description: prefilled syringe injection intramuscular
Study NCT06796348 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation alone
Description: RFA of a cancer in the thyroid gland.
Study NCT06796348 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: Hemithyroidectomy of the thyroid lobe with cancer
Study NCT05635396 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wearable, non invasive sensor for seizure detection
Description: The device consists of a chest strap and an electronics module that attaches to the strap. The device stores and transmits vital sign data including ECG, heart rate, respiration rate, body orientation and activity. This sensor will be worn every day (on a 24 hours basis) excepted during weekends for up to 4 weeks.
Study NCT05377450 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Engage Partial Knee
Description: Unicompartmental knee arthroplasty utilizing the Engage Partial Knee system with bone cement.
Study NCT06797960 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultra sound guided Injection of PRF intra articularly
Description: Intra articular injection of PRF
Study NCT06797960 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intra articular injection of HA
Description: Intra articular injection of HA
Study NCT06799689 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: esmadem education
Description: By providing information about Esma-i Husna, the journey of knowing oneself and character building with Esma-i Husna will be emphasized. It will be carried out with the aim of building on 99 names, namely Allah, Rahman and Rahim, and reducing depressive feelings by benefiting from the guidance of these names.In the second session, it will be explained through the names Esma-i Husna, Celal and Cemal in order to manage depressive feelings and contribute to positive coping. The togetherness of pain as well as happiness, ease along with difficulty, joy along with sadness in a balanced life will be discussed with the name Zü'l Celâl ve'l İkram and the study of Journey to perfection through the names Celal and Cemal. The meaning of existence and life in spirit will be discussed through the name Rab, the life cycle will be explained by establishing a relationship with the names Hafıd-Râfi, Kâbıd-Bâsıt, Muız-Müzil. In addition, it will be carried out within the framework of the name Hakim,
Study NCT06800274 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NAAGA (N-acetyl-aspartyl-glutamate) 49 mg/mL
Description: 80 patients were randomly assigned to NAAGA in single dose (49 mg/mL), instilled as 1 drop per eye four times daily for four weeks. Specific diagnostic tests and procedures for dry eye disease were performed at week 0 (baseline), week 2 and week 4.
Study NCT06800274 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: azelastine hydrochloride 0.05%
Description: 54 patients were randomly assigned to azelastine hydrochloride 0.05% instilled as 1 drop per eye 2 times a day in the conjunctival sac for for four weeks. Specific diagnostic tests and procedures for dry eye disease were performed at week 0 (baseline), week 2 and week 4.
Study NCT06798740 — intervention group
Intervention type: DEVICE
Intervention: Sugita Titanium Aneurysm Clip II
Description: Aneurysm clipping is a surgical procedure used to treat brain aneurysms.
Study NCT06794658 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: software
Description: Caaring is an electronic data collection notebook that allows patients to confidentially fill out data/questionnaires on their mobile phone and report them through an application that will be installed on the patient's mobile phone. Besides, This group (G_CAARING) will receive educational and prevention recommendations relative to diabetes.
Study NCT06795503 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel plus cyclophosphamide
Description: Docetaxel (T) at a dose of 75 mg/m² was administered intravenously on Day 1 of each cycle, and Cyclophosphamide (C) at a dose of 600 mg/m² was administered intravenously on Day 1 of each cycle as well.
Study NCT06795503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin, cyclophosphamide plus paclitaxel
Description: Patients in the control group received the EC-P regimen chemotherapy, with a cycle length of 21 days, for a total of 8 cycles. The specific treatment was as follows: Epirubicin (E) at a dose of 90 mg/m² and Cyclophosphamide (C) at a dose of 600 mg/m² were administered intravenously on Day 1 of each cycle for the first 4 cycles. This was followed by Paclitaxel (P) at a dose of 80 mg/m², administered intravenously on Days 1, 8, and 15 of each cycle for the subsequent 4 cycles.
Study NCT06792942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nature view curtain group
Description: During the fine needle biopsy, the patient will look at the nature view curtain on the ceiling.
Study NCT06800027 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SALSA group intervention: Going to lunch at the restaurant in a group and attending healthy eating workshops.
Description: The intervention group will dine at a selected and trained restaurant twice a week for 4 months (from March to June 2024). A facilitator will accompany the participants to the restaurant and supervise them. Once a month, a healthy habits and meal supplementation workshop will be held at the senior citizens' centre. Participants will not be required to pay for the meals at the restaurant or for participation in the workshops. The control group will receive standard care at their Primary Care Centre.~In order for the restaurant to provide appropriate services tailored to the users' needs, training will be conducted by professionals from the Alicia Foundation on how to manage the nutrition of elderly individuals and other participants in the study according to their dietary needs.
Study NCT06799130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: instrument-assisted soft tissue mobilization
Description: instrument-assisted soft tissue mobilization
Study NCT06799130 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: instrument-assisted soft tissue mobilization
Description: instrument-assisted soft tissue mobilization
Study NCT06799130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Description: Muscle energy technique
Study NCT06799130 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Muscle energy technique
Description: Muscle energy technique
Study NCT06800222 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: modern agents rehab
Description: rehabilitation interventions containing modern physical agents together with classical interventions
Study NCT06800222 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: classical rehab
Description: classical rehabilitation interventions
Study NCT06799325 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: acceptance and commitment therapy based stress management program
Description: The Stress Management Program Based on Acceptance and Commitment Therapy will be applied to the intervention group, consisting of 6 sessions, 1 session per week, and each session lasting 45 minutes.
Study NCT06799039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xylitol
Description: Xylitol is a sugar alcohol and considered a GRAS substance by the FDA. Patients will be consecutively enrolled into one of five dosing including 1g, 2g, 5g, 7g and 9g.
Study NCT06800157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug: LW402
Description: Oral tablets administered BID
Study NCT06800157 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Other: placebo
Description: Placebo to match LW402 administered BID
Study NCT06799663 — intervention group
Intervention type: OTHER
Intervention: activity questionnaire
Description: Physical activity questionnaire will be applied on children and adolescents to compare the effect of smart phone on physical fitness
Study NCT06799663 — intervention group
Intervention type: OTHER
Intervention: Raven's Progressive Matrices test (RPM)
Description: Raven's Progressive Matrices test will be applied on children and adolescents to compare the effect of smart phone on intelligence
Study NCT05377450 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Engage Partial Knee
Description: Unicompartmental knee arthroplasty utilizing the Engage Partial Knee system without bone cement.
Study NCT06799663 — intervention group
Intervention type: OTHER
Intervention: Postural assessment software
Description: Postural assessment software will be applied on children and adolescents to compare the effect of smart phone on posture
Study NCT06800248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: emodepside (BAY 44-4400)
Description: Treatment with single dose of oral 15 mg emodepside
Study NCT06800248 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mebendazole 100 MG
Description: Treatment with 100 mg mebendazole orally administered b.i.d. for 3 days
Study NCT06800248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: similar placebo to mebendazole
Description: Treatment with mebendazole similar placebo orally administered b.i.d. for 3 days
Study NCT06800248 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: matching placebo of emodepside
Description: Treatment with single dose of oral emodepside matching placebo
Study NCT06798363 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propranolol
Description: different dose
Study NCT06798363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propranolol
Description: different dose
Study NCT05576922 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetic-surgical approach + autogenous graft
Description: Coronally advanced flap with an autogenous graft (CTG)
Study NCT05576922 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prosthetic-surgical approach + graft substitute
Description: Coronally advanced flap with a graft substitute (collagen matrix and rhPDGF-BB)